Table 2.
Factors related to provision of IPTp in health facilities
|
Variable |
Urban |
Rural |
Total (%) |
||
|---|---|---|---|---|---|
| |
Public |
Private |
Public |
Private |
|
| 11 | 3 | 17 | 3 | 34 | |
|
How IPTp is delivered | |||||
| IPTp is offered in the facility |
10 |
2 |
15 |
2 |
29 (85.3) |
| DOT is practiced in the facility |
3 |
1 |
3 |
0 |
7 (20.6) |
| Woman is given drug to take home |
7 |
1 |
12 |
2 |
22 (64.7) |
|
Where drug used for IPTp is sourced | |||||
| Free from Ministry of Health |
10 |
0 |
15 |
0 |
25 (73.5) |
| Purchased |
0 |
2 |
0 |
2 |
4 (11.7) |
|
Facility occasionally has periods of drug stock-out |
6 |
1 |
4 |
1 |
12 (35.3) |
|
Source of drugs during stock-out | |||||
| Direct acquisition from market for sale |
1 |
1 |
1 |
1 |
4 (11.8) |
| Woman is given prescription to purchase on her own |
5 |
0 |
3 |
0 |
8 (23.5) |
|
Facilities with drugs on day of interview | |||||
| SP |
11 |
3 |
15 |
3 |
32 (94.1) |
| ACT |
8 |
3 |
16 |
3 |
30 (88.2) |
| Quinine |
7 |
1 |
5 |
3 |
16 (47.1) |
|
Complaints about the drug | |||||
| Side effect |
1 |
2 |
2 |
1 |
6 (17.6) |
| Irregularity of drug availability | 0 | 0 | 2 | 0 | 2 (5.9) |